Trial
NCT02722083
Exploratory Study for Allergy Relief Onset
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Bayer
Collaborators
—
Condition
Rhinitis, Allergic
Intervention
Chlorpheniramine maleate (BAY X002134)
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-12-12